Updated Jul 16, 2026
Wallace Peggy has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Peggy Wallace is listed as a Director of Cognition Therapeutics Inc. in the most recent SEC filing dated 2026-06-22. Beyond this SEC context, there is limited publicly available biographical information confirming her education, prior roles, or other board memberships. The name may appear in different orderings in filings (e.g., Peggy Wallace or Wallace Peggy). Based on the SEC context, she serves in a non-executive governance role with Cognition Therapeutics and may participate in oversight of strategy, governance, and financial reporting. No additional verified background details are available from the provided SEC context.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | CGTX | COGNITION THERAPEUTICS INC | A — Grant or award | 25.0K | $0.00 |
Peggy Wallace is listed as a Director of Cognition Therapeutics Inc. in the most recent SEC filing dated 2026-06-22. Beyond this SEC context, there is limited publicly available biographical information confirming her education, prior roles, or other board memberships. The name may appear in different orderings in filings (e.g., Peggy Wallace or Wallace Peggy). Based on the SEC…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Wallace Peggy profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.